National Academy of Sciences of Belarus

10.11.2026

The Academy of Sciences has identified the implementers of events within the framework of the State Program “Science for Economy and Society” for 2026–2030

In accordance with Protocol No. 7, dated November 3, 2026, of the meeting of the National Academy of Sciences of Belarus’s selection committee to choose implementers for the activities of the State Program "Science for the Economy and Society" for 2026–2030, the implementers for these activities have been determined:

- Unitary Enterprise "Geoinformation Systems" – for the event "Development of a monitoring system for geophysical parameters of near-Earth space, using space and land segments";

- Unitary Enterprise "Geoinformation Systems" – for the event: "Development of a technology for identifying updated data on spatial terrain features by processing diverse information sources, in order to support decision-making regarding the updating of cartographic products, utilizing space-based remote sensing data";

- State Scientific and Production Association "Chemical Synthesis and Biotechnologies" – for the event: "Developing the foundations for next-generation microbial biotechnologies for the bioregulation of soil microbial community composition, as well as for the protection and enhancement of crop stress tolerance against extreme abiotic and biotic factors";

- State Scientific and Production Association "Chemical Synthesis and Biotechnologies" – for the event: "Development of a biotechnological platform for regulating the gastrointestinal microbiome in poultry, pigs, and fish";

- State Enterprise "AKADEMFARM" – for the event: "Development of manufacturing technologies for solid-phase immunosorbent test systems for the detection of tumor markers associated with malignant neoplasms of the gastrointestinal tract tumor markers CA 19-9 and CA 72-4)";

- State Enterprise "AKADEMFARM" – for the event: "Development of manufacturing technologies for solid-phase immunosorbent test systems for the detection of IgM and IgG class antibodies against cytomegalovirus (CMV), and for the determination of the avidity of IgG class antibodies against CMV."